Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member

Published on by Cardiology and Cardiovascular Medicine

Assoc. Prof. Dr. Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member

Istanbul University-Cerrahpasa Cardiology Institute | Turkey

Umit Yaşar Sinan is an accomplished cardiovascular specialist whose career reflects sustained academic excellence, broad clinical expertise, and meaningful contributions to contemporary cardiology. After completing rigorous medical and cardiology training at leading institutions, he advanced rapidly through academic ranks and currently serves as an Associate Professor of Cardiology, where he is recognized for his dedication to research, teaching, and advanced patient care. His international experience includes focused work in adult congenital heart disease and pulmonary hypertension at a major UK referral center, strengthening his profile in complex cardiac conditions. Over the years, he has cultivated deep clinical interests spanning echocardiography, invasive cardiology, structural heart disease, pulmonary hypertension, adult congenital heart disease, heart failure, and atherosclerosis. His scholarly productivity is reflected in 90 scientific documents, which have collectively received 559 citations from 531 sources, supporting an h-index of 14 an indicator of his growing influence in cardiovascular research. He remains actively engaged in professional communities, holding memberships and leadership roles across prominent international and national cardiology societies, where he contributes to collaborative initiatives in acute cardiovascular care, imaging, valvular heart disease, congenital heart disease, and pulmonary vascular disorders. Through this blend of academic leadership, clinical depth, and research impact, he continues to shape advancements in cardiology both within his institution and across the broader scientific community.

Profile: Scopus | Orcid

Featured Publications

Yaylalı, Y. T., Yağmur, B., Sinan, Ü. Y., Meriç, M., Başarıcı, İ., Kılıçkıran Avcı, B., Şenol, H., Nalbantgil, S., Küçükoğlu, S., & Öngen, Z. (2023). Risk assessment tool implementation in congenital heart disease-associated pulmonary arterial hypertension. Anatolian Journal of Cardiology, 27(8), 479-485.

Kocabaş, U., Ergin, İ., Kıvrak, T., Yılmaz Öztekin, G. M., Tanık, V. O., Özdemir, İ., Avcı Demir, F., Doğduş, M., Şen, T., Altınsoy, M., Üstündağ, S., Urgun, Ö. D., Sinan, Ü. Y., Uygur, B., Yeni, M., & Özçalık, E. (2023). Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction. ESC Heart Failure, 10(6), 3677-3689.

Akyıldız Akçay, F., Sinan, Ü. Y., Gürbüz, D. Ç., Şafak, Ö., Kaya, H., Yüksek, Ü., & Zoghi, M. (2023). Gender-related differences in patients with acute heart failure: Observation from the Journey Heart Failure-Turkish Population Study. Anatolian Journal of Cardiology, 27(11), 639-649.

Sinan, U. Y., Serin, E., Keskin-Meriç, B., & Arat-Ozkan, A. (2023). Cre8 drug eluting stent performance in daily cardiology practice. IMR Press, 24(2), 53.

Şabanoğlu, C., Sinan, Ü. Y., Akboğa, M. K., Çoner, A., Gök, G., Kocabaş, U., Bekar, L., Gazi, E., Cengiz, M., Kılıç, S., İnanç, İ. H., Çakmak, H. A., & Zoghi, M. (2023). Long-term prognosis of patients with heart failure: Follow-up results of Journey HF-TR study population. Anatolian Journal of Cardiology, 27(1), 26-33.

Xinke Wang | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Xinke Wang | Heart Failure | Best Researcher Award

China Medical University | China

Ms. Xinke Wang is a dedicated researcher and master’s scholar at China Medical University, specializing in cardiovascular diseases with a particular focus on heart failure. Her academic background integrates clinical and epidemiological research, emphasizing the translation of basic scientific discoveries into effective clinical applications. Through her work, she strives to elucidate novel mechanisms underlying heart failure progression and identify innovative therapeutic strategies to improve patient care and outcomes. Ms. Wang has contributed significantly to various aspects of research, including data curation, conceptualization, methodology design, software development, formal analysis, validation, and manuscript preparation. Her ability to bridge clinical insight with analytical expertise underscores her commitment to advancing cardiovascular medicine. Collaborating with esteemed institutions such as Kailuan General Hospital, she actively engages in multidisciplinary research aimed at improving diagnostic precision and treatment efficacy in heart failure management. Her growing body of work reflects both academic rigor and practical relevance, contributing to the evolving landscape of cardiovascular research. Ms. Wang’s scholarly efforts exemplify a strong dedication to medical innovation, evidence-based practice, and collaborative science. By combining her expertise in epidemiology with a passion for clinical application, she continues to advance the understanding of cardiovascular health and disease, fostering new approaches that hold promise for enhancing patient outcomes and shaping the future of cardiovascular research.

Profile: Orcid

Featured Publication

Wang, X., Ning, N., Li, Y., Huang, R., Liu, Y., Miao, Y., Zhang, W., Chen, S., Gao, J., Wu, S., et al. (2025). Association of scores on the Life’s Essential 8 scale with progression to type 2 diabetes, heart failure, and death: A multistate Markov model analysis. Maturitas.

Yingqiang Du | Myocardial Infarction | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Yingqiang Du | Myocardial Infarction | Best Researcher Award

Dr. Yingqiang Du, Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University; Suzhou Municipal Hospital; Gusu School, Nanjing Medical University, China

Dr. Yingqiang Du is a renowned cardiology researcher at The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University, China. His research focuses on myocardial infarction and ischemic heart disease, exploring inflammation, fibrosis, metabolic remodeling, and novel therapeutic strategies. As the first or corresponding author of multiple high-impact publications, he has significantly contributed to cardiovascular medicine. His work bridges basic and clinical research, influencing treatment advancements and patient care. With ongoing projects funded by prestigious grants, Dr. Du continues to drive innovation in cardiology, shaping the future of cardiovascular health research.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

📚 EARLY ACADEMIC PURSUITS:

Dr. Yingqiang Du began his academic journey with a strong foundation in medical sciences, focusing on cardiology and cardiovascular research. His early education provided him with a deep understanding of human physiology, pathology, and the complexities of ischemic heart disease. With a keen interest in myocardial infarction and its underlying mechanisms, he pursued specialized training and research, laying the groundwork for his future contributions to the field.

🏥 PROFESSIONAL ENDEAVORS:

Currently, Dr. Du is affiliated with The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University. As a researcher and academic professional, he has taken on significant responsibilities in both clinical and experimental cardiology. His work bridges the gap between theoretical research and practical applications, ensuring that scientific findings translate into improved patient care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Dr. Du’s research primarily centers on myocardial infarction and ischemic heart disease. His studies delve into various aspects, including:

  • The role of inflammation and fibrosis in cardiovascular conditions.
  • The impact of environmental factors, such as micro(nano)plastics, on heart disease.
  • Novel therapeutic approaches involving bioactive compounds like resveratrol and muscone.
  • The involvement of metabolic remodeling and inflammasome activation in aging cells. His extensive work provides crucial insights into the prevention, diagnosis, and treatment of cardiac disorders.

🌟 IMPACT AND INFLUENCE:

Dr. Du’s research has had a profound impact on the field of cardiology. His studies have contributed to a better understanding of the molecular mechanisms of myocardial infarction and fibrosis, paving the way for new treatment modalities. His findings have influenced clinical practices and have been referenced in various medical and scientific discussions worldwide.

📖 ACADEMIC CITES:

As an established researcher, Dr. Du has authored multiple high-impact publications in reputed journals, including:

  • Journal of Hazardous Materials
  • Clinical and Translational Medicine
  • Experimental and Therapeutic Medicine
  • Bioengineered
  • American Journal of Translational Research These publications, where he serves as either the first or corresponding author, reflect his credibility and expertise in the field. His work has been widely cited by peers, demonstrating its relevance and significance.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Du’s contributions to cardiology are paving the way for future breakthroughs in cardiovascular medicine. His research findings are not only enhancing current medical knowledge but also inspiring upcoming researchers to explore novel therapeutic strategies. Moving forward, his work is expected to contribute significantly to:

  • The development of innovative drug treatments for myocardial infarction.
  • The formulation of preventive measures against ischemic heart disease.
  • The exploration of new molecular pathways for better cardiovascular health. His ongoing commitment to research excellence ensures that his legacy will continue to shape the future of cardiology.

🌍CONCLUSION:

Dr. Yingqiang Du is a distinguished researcher whose groundbreaking contributions to cardiology have significantly advanced the understanding of myocardial infarction and ischemic heart disease. His extensive studies on inflammation, fibrosis, and metabolic remodeling have influenced both clinical practices and future research directions. With multiple high-impact publications and ongoing projects, his work continues to shape modern cardiovascular medicine.

TOP NOTABLE PUBLICATION

Title:  Exposure to polyethylene terephthalate micro(nano)plastics exacerbates inflammation and fibrosis after myocardial infarction by reprogramming the gut and lung microbiota and metabolome

Authors: X., Gu, Xin, Z., Zhang, Zhixuan, L., Zhao, Lin, … X., Wang, Xiaoyan, Y., Du, Yingqiang

Journal:  Journal of Hazardous Materials

Year: 2025